Colony Group’s Privia Health PRVA Stock Holding History

Colony Group’s Portfolio PRVA Stock Details PRVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$1.54M	Sell	66,800 -2,244	-3%	-$57.1K	0.02%	370
2023 Q2	$1.8M	Sell	69,044 -404	-0.6%	-$10.7K	0.03%	362
2023 Q1	$1.92M	Sell	69,448 -1,276	-2%	-$33.7K	0.03%	355
2022 Q4	$1.61M	Buy	70,724 +23,794	+51%	+$662K	0.02%	410
2022 Q3	$1.6M	Sell	46,930 -23,400	-33%	-$865K	0.03%	358
2022 Q2	$2.05M	Buy	70,330 +908	+1%	+$23.1K	0.04%	327
2022 Q1	$1.86M	Buy	69,422 +11,014	+19%	+$260K	0.03%	364
2021 Q4	$1.51M	Sell	58,408 -1,210	-2%	-$30.2K	0.03%	371
2021 Q3	$1.41M	Buy	+59,618	New	+$2.08M	0.03%	365

Other funds holding PRVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Colony Group's PRVA Position: Q3 2023 in Review

Colony Group reduced its Privia Health (PRVA) stake by 3.3% in Q3 2023, selling an estimated $57.1K and leaving 66,800 shares worth $1.54M. The position accounts for 0.02% of the portfolio, ranked #370.

Colony Group first reported a position in PRVA in Q3 2021 and has held it in 9 quarters since. The position peaked at $2.05M in Q2 2022. 218 funds tracked by Wall St. Rank hold PRVA as of Q3 2023.

Colony Group held 66,800 shares of Privia Health worth $1.54M as of Q3 2023.
Colony Group sold 2,244 Privia Health shares in Q3 2023, an estimated $57.1K.
Privia Health made up 0.02% of Colony Group's portfolio in Q3 2023, its #370 holding.
Colony Group first reported a position in Privia Health in Q3 2021 and has held it in 9 quarters since.
Colony Group's Privia Health position peaked at $2.05M in Q2 2022.
218 funds tracked by Wall St. Rank held Privia Health as of Q3 2023.

Based on Colony Group's 13F filing for Q3 2023, filed 14 Nov 2023.